Clinical Trial Update: Coherex WAVECREST I Left Atrial Appendage Occlusion Study

View source ↗

Summary

The WAVECREST I trial evaluating left atrial appendage occlusion in non-valvular atrial fibrillation has completed. The update notes the study status but does n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• WAVECREST Left Atrial Appendage Occlusion System

Snippet

Sponsor: Coherex Medical | Conditions: Non-valvular Paroxysmal, Persistent, or Permanent Atrial Fibrillation, LAA Anatomy Amenable to Treatment by Percutaneous Technique | Status: COMPLETED